Workflow
Chemours(CC) - 2024 Q2 - Quarterly Report

Financial Performance - Net sales decreased by 105million(or6105 million (or 6%) to 1.5 billion for Q2 2024 compared to 1.6billioninQ22023,primarilyduetoa61.6 billion in Q2 2023, primarily due to a 6% decrease in price [259]. - For the six months ended June 30, 2024, net sales decreased by 292 million (or 9%) to 2.9billionfrom2.9 billion from 3.2 billion in the same period in 2023, driven by a 5% decrease in price and a 3% decrease in volume [260]. - Titanium Technologies segment net sales decreased by 34million(or534 million (or 5%) to 673 million for the three months ended June 30, 2024, primarily due to a 7% decrease in price [277]. - Thermal & Specialized Solutions segment net sales decreased by 10million(or210 million (or 2%) to 513 million for the three months ended June 30, 2024, primarily due to a 4% decrease in price [283]. - Advanced Performance Materials segment net sales decreased by 48million(or1248 million (or 12%) to 339 million for the three months ended June 30, 2024, primarily due to a 7% decrease in price and a 4% decrease in volume [287][288]. - Performance Solutions portfolio's net sales were 133millionforQ22024,downfrom133 million for Q2 2024, down from 140 million in Q2 2023, while Advanced Materials portfolio's net sales decreased from 247millionto247 million to 206 million in the same period [290]. - Net sales for the six months ended June 30, 2024, were 1,982million,withagrossprofitof1,982 million, with a gross profit of 298 million [326]. Expenses and Costs - Cost of goods sold (COGS) decreased by 1million(orlessthan11 million (or less than 1%) to 1.2 billion for Q2 2024, and by 107million(or4107 million (or 4%) to 2.3 billion for the six months ended June 30, 2024 [261]. - Selling, general, and administrative (SG&A) expenses decreased by 640million(or82640 million (or 82%) to 139 million for Q2 2024, primarily due to litigation-related charges of 592 million recorded in Q2 2023 [262]. - Research and development (R&D) expenses decreased by 2 million (or 7%) to 26millionforQ22024,drivenbytransformationinitiativeswithintheTitaniumTechnologiesbusiness[263].Interestexpense,netincreasedby26 million for Q2 2024, driven by transformation initiatives within the Titanium Technologies business [263]. - Interest expense, net increased by 18 million (or 38%) to 66millionforQ22024,primarilyduetohigherinterestratesonvariableratedebtandincreaseddebtprincipal[266].Corporateexpensesandunallocateditemstotaled66 million for Q2 2024, primarily due to higher interest rates on variable rate debt and increased debt principal [266]. - Corporate expenses and unallocated items totaled 207 million for the six months ended June 30, 2024, down from 820millioninthesameperiodof2023[296].CashFlowandLiquidityTotalunrestrictedcashandcashequivalentswere820 million in the same period of 2023 [296]. Cash Flow and Liquidity - Total unrestricted cash and cash equivalents were 604 million as of June 30, 2024, with 432millionheldbyforeignsubsidiaries[298].TheavailabilityundertheRevolvingCreditFacilitywas432 million held by foreign subsidiaries [298]. - The availability under the Revolving Credit Facility was 852 million as of June 30, 2024, net of 48millioninoutstandinglettersofcredit[298].Thecompanyincurredanet48 million in outstanding letters of credit [298]. - The company incurred a net 895 million usage of cash in operating activities for the six months ended June 30, 2024, compared to a net 57millionusageinthesameperiodof2023[301].Thecompanyacceleratedthecollectionofapproximately57 million usage in the same period of 2023 [301]. - The company accelerated the collection of approximately 128 million of accounts receivable in the first half of 2024, compared to 205millioninthesameperiodof2023[303].Thecompanyreceivedapproximately205 million in the same period of 2023 [303]. - The company received approximately 259 million of net cash in the U.S. through intercompany loans and dividends during the six months ended June 30, 2024 [304]. - Cash used for operating activities increased to 910millioninthefirsthalfof2024,primarilyduetothereleaseof910 million in the first half of 2024, primarily due to the release of 592 million from the qualified settlement fund [313]. - Cash used for investing activities was 171millioninthefirsthalfof2024,mainlyforproperty,plant,andequipmentpurchasestotaling171 million in the first half of 2024, mainly for property, plant, and equipment purchases totaling 175 million [314]. Environmental and Sustainability Initiatives - The company aims to achieve ambitious Corporate Responsibility Commitment goals by 2030, focusing on sustainability and long-term earnings growth [254]. - The company is committed to integrating sustainability across its operations and investing in R&D to develop safer and more efficient products [254]. - Chemours aims for a 60% reduction in Scope 1 and Scope 2 absolute GHG emissions by 2030, aligning with its Environmental Leadership goals [359]. - The company has set a new Scope 3 target to reduce emissions by 25% per ton of product by 2030, approved by the Science Based Targets initiative in May 2024 [360]. - Chemours has committed to a 99% or more reduction of air and water process emissions of fluorinated organic chemicals by 2030 [359]. - The company is continuously evaluating market trends and opportunities for low-carbon and energy-efficient products in response to evolving climate-related legislation [361]. - The Chemours Company aims to achieve a goal of avoiding 325 million tons of carbon dioxide equivalent emissions globally by the end of 2025 through its low GWP Opteon™ products [362]. Legal and Regulatory Matters - The company accrued litigation costs of 175millionasofJune30,2024,whichincludesa175 million as of June 30, 2024, which includes a 55 million settlement with the State of Ohio and a 13millionsupplementalpaymenttotheStateofDelaware[307].TheChemoursCompanyanticipatessignificantcashpaymentsforknowncontractualobligations,including13 million supplemental payment to the State of Delaware [307]. - The Chemours Company anticipates significant cash payments for known contractual obligations, including 580 million for environmental remediation liabilities as of June 30, 2024, with 127millionclassifiedascurrent[306].ThecompanyhasestablishedanescrowaccountforpotentialfuturelegacyPFASliabilities,withanextescrowpaymentof127 million classified as current [306]. - The company has established an escrow account for potential future legacy PFAS liabilities, with a next escrow payment of 50 million expected by September 30, 2025, and annual payments through 2028 [307]. - The estimated earliest entry into force of PFAS restrictions in the EU is 2025, pending completion of the regulatory process [370]. - Chemours has appealed the EU's decision to list HFPO Dimer Acid as a Substance of Very High Concern, which may lead to future regulatory restrictions [368]. Assets and Liabilities - The Chemours Company reported a decrease in total current assets to 2.937billionasofJune30,2024,downfrom2.937 billion as of June 30, 2024, down from 3.835 billion at December 31, 2023 [317]. - Accounts and notes receivable increased by 286million(or47286 million (or 47%) to 896 million at June 30, 2024, driven by higher sales in Q2 2024 [318]. - Current liabilities decreased to 1.557billionatJune30,2024,from1.557 billion at June 30, 2024, from 2.486 billion at December 31, 2023, primarily due to a reduction in accounts payable [321]. - Long-term liabilities as of June 30, 2024, were 4,867million,slightlydownfrom4,867 million, slightly down from 4,931 million as of December 31, 2023 [327]. - Total environmental remediation liabilities decreased from 590millionasofDecember31,2023,to590 million as of December 31, 2023, to 580 million as of June 30, 2024 [341]. - The five most significant environmental remediation sites account for 81% of total accrued liabilities, with expected spending of 171millionoverthenextthreeyears[341].ForeignCurrencyandInterestRateManagementAsofJune30,2024,Chemourshad11foreigncurrencyforwardcontractswithagrossnotionalvalueof171 million over the next three years [341]. Foreign Currency and Interest Rate Management - As of June 30, 2024, Chemours had 11 foreign currency forward contracts with a gross notional value of 208 million, resulting in net gains of 3millionforthequarter[374].Thecompanyenteredintointerestrateswapswithanotionalvalueof3 million for the quarter [374]. - The company entered into interest rate swaps with a notional value of 300 million to mitigate cash payment volatility, recognizing pre-tax gains of 1millionforthequarterendedJune30,2024[377].Thecompanydesignatedeurodenominateddebtasahedgeofitsnetinvestmentininternationalsubsidiaries,recognizingpretaxgainsof1 million for the quarter ended June 30, 2024 [377]. - The company designated euro-denominated debt as a hedge of its net investment in international subsidiaries, recognizing pre-tax gains of 13 million and $27 million for the three and six months ended June 30, 2024, respectively [376].